Malon, Prince Rovi A.
HRN: 14-68-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2024
CEFUROXIME 1.5GM (VIAL)
01/03/2024
01/10/2024
IV
1.5g
Q8h
Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes